United Therapeutics | UTHR - Pasivo Circulante

Precio De Mercado
585.58
Cambio Diario
13.38 2.34%
Mensual
3.51%
Anual
90.79%
Q2 Expectativa
558.54




Pasivo Circulante Cambio Fecha
Amarin USD 179.64M 14.82M 2026-03
Ardelyx USD 109.57M 20.96M 2026-03
Baxter International USD 3.69B 723M 2026-03
Bayer EUR 32.58B 3.63B 2025-12
BioCryst Pharmaceuticals USD 196.07M 5.83M 2025-12
Biogen USD 3B 350.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Esperion Therapeutics USD 300.81M 58.22M 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Insmed USD 468.87M 51.66M 2025-12
Ionis Pharmaceuticals USD 717M 66M 2026-03
J&J USD 57.72B 3.59B 2026-03
Lexicon Pharmaceuticals USD 20.87M 853K 2025-12
Moderna USD 2.4B 408M 2026-03
Omeros USD 85.5M 2.28M 2025-06
Pfizer USD 34.35B 2.64B 2026-03
PTC Therapeutics USD 968.43M 102.18M 2025-12
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Teva Pharmaceutical Industries USD 13.53B 76M 2026-03
United Therapeutics USD 599.1M 38.5M 2026-03
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03